Home › Calculator › GBLX Dividend Calculator 2026
GBLX Dividend DRIP Calculator 2026
666666.67% YieldHealthcareGB Sciences, Inc. · OTC
Price: $0.00 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When GBLX pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your GBLX snowball 📈
$10,000 in GBLX → $1.6960507593779877e+33M in 10 years · $141,316,365,826,624,950,000,000,000,000,000,000,000.00/month
About GB Sciences, Inc. (GBLX) — Dividend Analysis 2026
Operating across North America and Europe, GB Sciences, Inc. is dedicated to the research and development of plant-based pharmaceuticals. The company specializes in crafting cannabinoid-inspired medications and complex therapeutic formulations intended for the prescription drug market. Its extensive intellectual property portfolio addresses a variety of medical conditions, with programs currently in pre-clinical animal stages. These include initiatives for Parkinson's disease, neuropathic and chronic pain, COVID-related cytokine release syndrome, depression/anxiety, and cardiovascular ailments. Formed in 2001 and headquartered in Las Vegas, Nevada, the company was formerly known as Growblox Sciences, Inc. before rebranding in October 2016.
Compare GBLX with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full GBLX DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open GBLX position with:
🌍 GBLX Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold GBLX.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 666666.67% | 666663.87% | $66,666,667 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 566666.67% | 566663.87% | $56,666,667 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 533333.34% | 533330.54% | $53,333,334 / yr |
| 🇬🇧 UK ISA | 0% | 666666.67% | 666663.87% | $66,666,667 / yr |
| 🇬🇧 UK Taxable | 8.75% | 608333.34% | 608330.54% | $60,833,334 / yr |
| 🇨🇦 TFSA | 0% | 666666.67% | 666663.87% | $66,666,667 / yr |
| 🇨🇦 CA Taxable | 25% | 500000.00% | 499997.20% | $50,000,000 / yr |
| 🇦🇺 Super (pension) | 15% | 566666.67% | 566663.87% | $56,666,667 / yr |
| 🇦🇺 AU Taxable | 30% | 466666.67% | 466663.87% | $46,666,667 / yr |
| 🇩🇪 DE Taxable | 26.375% | 490833.34% | 490830.54% | $49,083,334 / yr |
| 🇫🇷 FR Taxable | 30% | 466666.67% | 466663.87% | $46,666,667 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 GBLX Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 GBLX Dividend Payment Schedule
GBLX pays quarterly — 4 times per year. Next ex-div: TBD.
📊 GBLX vs Healthcare Benchmarks
How GBLX compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GBLX sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ GBLX Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Buy | 2018-07-11 | 3,615 | $0.41 | $1.5K | ||
| Buy | 2018-07-11 | 11,915 | $0.41 | $4.9K | ||
| Buy | 2018-07-11 | 20,000 | $0.41 | $8.2K | ||
| Buy | 2018-07-11 | 1,250 | $0.41 | $508.00 | ||
| Buy | 2018-07-11 | 30,000 | $0.41 | $12.2K | ||
| Buy | 2018-07-11 | 23,184 | $0.40 | $9.3K | ||
| Buy | 2018-07-11 | 10,000 | $0.40 | $4.0K | ||
| Other | 2017-11-27 | 937,500 | $0.24 | $225.0K | ||
| Other | 2016-06-01 | 1,400,000 | $0.30 | $420.0K | ||
| Sale | 2017-08-02 | 50,000 | $0.26 | $12.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GBLX dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
GB Sciences, Inc. (GBLX) is currently trading at $0.00, 100% below its 52-week high. The current dividend yield is 666666.67% based on an annual payout of $2.00 per share.
GBLX (GB Sciences, Inc.) — 666666.67% Dividend Yield Analysis
GB Sciences, Inc. (GBLX) is a healthcare stock currently trading at $0.00 with a dividend yield of 666666.67%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, GBLX has grown its dividend at a compound annual rate of 50.0%.
- Above-average yield (666666.67%) may signal elevated risk — verify sustainability.
Auto-generated from live market data. For educational purposes only — not financial advice.